| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 862 | 8.483 | 7.849 | 13.403 | 14.407 | 224.572 | 396.230 | 470.583 |
| Total Income - EUR | - | - | 902 | 8.483 | 7.849 | 13.403 | 14.407 | 297.823 | 411.422 | 488.711 |
| Total Expenses - EUR | - | - | 1.155 | 6.266 | 5.478 | 7.090 | 21.153 | 190.120 | 258.217 | 276.106 |
| Gross Profit/Loss - EUR | - | - | -253 | 2.217 | 2.371 | 6.312 | -6.745 | 107.703 | 153.204 | 212.606 |
| Net Profit/Loss - EUR | - | - | -280 | 1.962 | 2.290 | 6.186 | -6.890 | 105.457 | 149.242 | 198.488 |
| Employees | - | - | 0 | 0 | 0 | 1 | 1 | 6 | 7 | 7 |
Check the financial reports for the company - Ace Implant Lab S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 158 | 10 | 0 | 0 | 202.302 | 166.014 | 227.812 | 183.064 |
| Current Assets | - | - | 3.240 | 4.654 | 4.593 | 10.672 | 21.978 | 67.681 | 96.508 | 203.102 |
| Inventories | - | - | 715 | 4.617 | 0 | 0 | 14.002 | 43 | 542 | 0 |
| Receivables | - | - | 361 | 0 | 0 | 0 | 342 | 6.763 | 6.831 | 819 |
| Cash | - | - | 2.163 | 37 | 4.593 | 10.672 | 7.634 | 60.875 | 89.135 | 202.283 |
| Shareholders Funds | - | - | -236 | 1.730 | 4.007 | 10.117 | 3.004 | 108.470 | 149.315 | 250.713 |
| Social Capital | - | - | 44 | 43 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | - | - | 3.634 | 2.934 | 585 | 554 | 123.150 | 6.215 | 71.548 | 50.702 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 98.126 | 119.010 | 103.458 | 84.751 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3250 - 3250" | |||||||||
| CAEN Financial Year |
3250
|
|||||||||
Comments - Ace Implant Lab S.r.l.